EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Direct Economic Burden of Post‐Cancer Treatment Pain Among Cancer Survivors in the United States: A Population‐Based Retrospective Longitudinal Study

Yves Paul Vincent Mbous iD, Rowida Mohamed iD, Uche Osahor iD, Traci J LeMasters iD

The International Journal of Health Planning and Management · 2025

DOI: 10.1002/hpm.3932 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The International Journal of Health Planning and Management, 2025. Verfasst von Yves Paul Vincent Mbous und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Systems and Policy, School of Pharmacy, West Virginia University, Morgantown, West Virginia, USA. Hauptthemen laut MEDLINE: Cancer Survivors, Cost of Illness, Health Expenditures, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Post‐cancer treatment pain (PCTP) is prevalent among cancer survivors but remains understudied. It is critical to quantify PCTP prevalence over time and to estimate the resulting short and long‐term incremental healthcare expenditures (total, third‐party, and out‐of‐pocket) and out‐of‐pocket burden among cancer survivors.

Methods

A longitudinal retrospective cohort design was used. To identify cancer survivors (≥ 18 years) with PCTP, the Medical Expenditure Panel Survey (MEPS) and its supplementary Cancer Self‐Administered Questionnaire (CSAQ)were used. Recycled predictions from generalised linear models (GLM) with log‐link and gamma distribution were used to estimate annual incremental healthcare expenditures at different PCTP gradations over time. To account for covariate imbalance, sensitivity analysis using inverse probability weighting was conducted.

Results

2125 cancer survivors had PCTP. Post‐cancer treatment, 10.5%–24.2% of survivors experienced some form of chronic PCTP, whereas between 21.9%–5.1% experienced acute PCTP. Across the survivorship journey, the adjusted total annual incremental healthcare expenditures were the highest among cancer survivors with moderate chronic PCTP (< 1‐year post‐cancer treatment), and severe chronic PCTP, (≥ 5 years post‐cancer treatment) compared to survivors with no pain, reaching respectively, $27.3 and $40.2 billion nationally. There was a significant high out‐of‐pocket burden among cancer survivors with severe chronic PCTP compared to those with no pain.

Conclusion

These findings highlight the persistent financial burden of PCTP but also the critical need for effective pain management alongside the use of patient‐reported outcomes for pain among cancer survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsCost of IllnessHealth ExpendituresNeoplasmsCancer PainHumansLongitudinal StudiesMaleRetrospective StudiesFemaleMiddle AgedUnited StatesAdultAgedSurveys and QuestionnairesYoung Adult

Stichwörter der Autor:innen

cancer populationhealthcare expendituresinverse probability weightsout‐of‐pocketpain syndromethird‐party

Autor:innen und Institutionen

  • Department of Pharmaceutical Systems and Policy, School of Pharmacy, West Virginia University, Morgantown, West Virginia, USA.
  • Biological Sciences Division, Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois, USA.
  • Lane Department of Computer Science and Electrical Engineering, School of Engineering, West Virginia University, Morgantown, West Virginia, USA.
  • OPEN Health, Parsippany, New Jersey, USA.

ORCID-Profile: Yves Paul Vincent Mbous, Rowida Mohamed, Uche Osahor, Traci J LeMasters

Zitieren

APA

Mbous, Y. P. V., Mohamed, R., Osahor, U., & LeMasters, T. J. (2025). Direct Economic Burden of Post‐Cancer Treatment Pain Among Cancer Survivors in the United States: A Population‐Based Retrospective Longitudinal Study. The International Journal of Health Planning and Management. https://doi.org/10.1002/hpm.3932

Vancouver

Mbous YPV, Mohamed R, Osahor U, LeMasters TJ. Direct Economic Burden of Post‐Cancer Treatment Pain Among Cancer Survivors in the United States: A Population‐Based Retrospective Longitudinal Study. The International Journal of Health Planning and Management. 2025. doi:10.1002/hpm.3932

BibTeX
@article{Mbous2025,
  author = {Mbous, Yves Paul Vincent and Mohamed, Rowida and Osahor, Uche and LeMasters, Traci J},
  title = {Direct Economic Burden of Post‐Cancer Treatment Pain Among Cancer Survivors in the United States: A Population‐Based Retrospective Longitudinal Study},
  journal = {The International Journal of Health Planning and Management},
  year = {2025},
  doi = {10.1002/hpm.3932}
}
Kostenlos starten →